Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Category: eQMS

Hands, laboratory or tablet screen for science research, medical analytics or bacteria vaccine stud
eQMS

Augmented Analytics: Your Key to Faster Drug Discovery

The pharmaceutical industry is evolving rapidly, with augmented analytics leading the transformation. By leveraging AI and Natural Language Processing (NLP), companies can gain real-time insights, manage risks, and improve decision-making across drug development, clinical trials, and supply chain management.

Read More »
SOP management involves not only the creation and revision of these documents but also ensuring that they are easily accessible to all relevant personnel.
eQMS

Smart SOPs: AI Transforming SOP Management

In the pharmaceutical industry, managing Standard Operating Procedures (SOPs) is increasingly complex due to regulatory demands. This article highlights the challenges of SOP retrieval and showcases how the AI-driven Zamann Retrieval Augmented System (ZaRAS) transforms SOP management through enhanced efficiency, compliance, and streamlined access to critical information.

Read More »
Computerized System Validation

EU Annex 11 and its comparison with FDA 21 CFR Part 11

Unlock the secrets of regulatory compliance comparison of EU Annex11 and 21CFR Part 11! These guidelines differ in scope and requirements, ensuring your computerized systems meet the highest standards in pharmaceutical and life sciences.

Read More »
eQMS

Discover how to integrate AI Into Quality Management Workflows

The AI revolution brings unparalleled opportunities and challenges across all sectors, with life sciences and healthcare standing at the forefront due to their critical role in enhancing public health and quality of life. These areas hold immense potential for AI to make groundbreaking improvements but also face significant risks that cannot be ignored.

Read More »
eQMS

Mastering 21 CFR Part 11 Compliance: The Ultimate Guide

In the life sciences sector, aligning with 21 CFR Part 11 isn’t just good practice—it’s crucial. This regulation, part of the Code of Federal Regulations, ensures the reliability of electronic records and signatures for FDA-regulated entities like pharmaceuticals, medical device manufacturers, and biotech firms. Let’s simplify what this means and how to stay compliant.

Read More »
eQMS

The future of Cloud Quality Management Systems in Pharma

This blog post will dive deep into the heart of cloud digitalization for QMS, exploring its benefits, key features, and practical implementation strategies. We’ll also sprinkle in some expert opinions, case studies, and eye-catching images to paint a vivid picture of this game-changing evolution.

Read More »